Rossari Biotech Board to Meet on Oct 17 for Q2/H1 FY27 Results

Rossari Biotech Ltd has announced that a meeting of its Board of Directors is scheduled for Saturday, October 17, 2026. The main agenda for the meeting is to consider and approve the Unaudited Financial Results, both Standalone and Consolidated, for the quarter and half year ended September 30, 2026. Additionally, the company has informed that the trading window for dealing in its securities will remain closed for all designated persons and their immediate relatives from October 01, 2026, until 48 hours after the announcement of these financial results.